Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M204977200 on June 24, 2002

J. Biol. Chem., Vol. 277, Issue 39, 36399-36407, September 27, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/39/36399    most recent
M204977200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, A. J.
Right arrow Articles by Vasudevan, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, A. J.
Right arrow Articles by Vasudevan, S. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Interdomain Region of Dengue NS5 Protein That Binds to the Viral Helicase NS3 Contains Independently Functional Importin beta 1 and Importin alpha /beta -Recognized Nuclear Localization Signals*

Andrew J. BrooksDagger , Magnus JohanssonDagger , Anna V. John§, Yibin XuDagger , David A. Jans§, and Subhash G. VasudevanDagger ||

From the Dagger  Department of Biochemistry and Molecular Biology, James Cook University, Queensland 4811, § Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, the Australian National University, Canberra, Australian Capital Territory 2601, and the  Department of Biochemistry and Molecular Biology, Box 13D, Monash University, Victoria 3800, Australia

Received for publication, May 21, 2002, and in revised form, June 20, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Dengue virus NS5 protein is a multifunctional RNA-dependent RNA polymerase that is essential for virus replication. We have shown previously that the 37- amino acid interdomain spacer sequence (residues 369X2KKX14KKKX11RKX3405) of Dengue2 NS5 contains a functional nuclear localization signal (NLS). In this study, beta -galactosidase fusion proteins carrying point mutations of the positively charged residues or truncations of the interdomain linker region (residues 369-389 or residues 386-405) were analyzed for nuclear import and importin binding activities to show that the N-terminal part of the linker region (residues 369-389, a/bNLS) is critical for nuclear localization and is recognized with high affinity by the conventional NLS-binding importin alpha /beta heterodimeric nuclear import receptor. We also show that the importin beta -binding site (residues 320-368, bNLS) adjacent to the a/bNLS, previously identified by yeast two-hybrid analysis, is functional as an NLS, recognized with high affinity by importin beta , and able to target beta -galactosidase to the nucleus. Intriguingly, the bNLS is highly conserved among Dengue and related flaviviruses, implying a general role for the region and importin beta  in the infectious cycle.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Dengue virus is a member of the genus Flavivirus within the family Flaviviridae that also contains the genera Pestivirus and Hepacivirus. There are around 70 viruses grouped in the Flavivirus genus, which includes yellow fever virus (YFV),1 Japanese encephalitis virus, Murray Valley encephalitis virus, Kunjin virus, and tick-borne encephalitis virus. Dengue virus causes a benign syndrome known as Dengue fever and a more severe illness, Dengue hemorrhagic fever or in its severest form Dengue shock syndrome (1-3). There are four serologically and phylogenetically distinguishable Dengue viruses (types 1-4), and the disease they cause is of substantial world wide significance to human health but is mostly restricted to tropical and sub-tropical areas because of its transmission by the Aedes aegypti mosquito (4).

Flaviviruses possess a single-strand, positive-sense RNA genome of around 11 kb, which is capped but not polyadenylylated, and encodes a single polyprotein including three structural and seven non-structural proteins in the order C-prM-E-NS1-NS2A-NS3-NS2B-NS2A-NS4B-NS5 (5, 6). Replication of flaviviruses occurs at membrane-associated replicase complexes localized in the perinuclear region. The replicase complex has been extensively characterized in several flaviviruses and includes NS1, NS2A, NS3, NS4A, and NS5 (7-12) and possibly some cellular proteins (13-15). Whereas the protein and RNA interactions of the replicase complexes still require detailed characterization, several recent studies (7, 17) have focused on the structure and function of the NS3 and NS5 proteins.

NS3 (69 kDa) is a multifunctional protein that has been shown to have protease, helicase, NTPase, and 5'-terminal RNA triphosphatase activities (16-19). NS5 (104 kDa) contains a well characterized RNA-dependent RNA polymerase activity associated with the C-terminal domain (20-24). Although there has been no function demonstrated for the N-terminal domain of NS5, it is predicted to be an S-adenosylmethionine transferase based on sequence comparison (25).

Whereas the primary replication activity involving Dengue NS5 occurs in the cytoplasm, a predominantly nuclear hyperphosphorylated form of NS5 has been reported in infected mammalian cells in the late stage of infection. The cytoplasmic form of NS5 is hypophosphorylated and able to interact with NS3, whereas the hyperphosphorylated form does not interact with NS3 (7). Phosphorylation of flavivirus NS5/NS5A proteins occurs at serine/threonine residues (26, 27). YFV NS5 is also phosphorylated and localized in the nucleus (28), whereas NS5 of other flaviviruses such as Japanese encephalitis virus and Kunjin virus have not been detected in the nucleus (8, 29).

Transport to the nucleus of proteins that are larger than 45 kDa requires intrinsic targeting signals called nuclear localization sequences (NLSs) (30-33). There are two main classes of basic type NLSs as follows: the simian virus 40 (SV40) large tumor antigen (T-ag) monopartite NLS type, consisting of a single cluster of basic amino acids (PKKKRKV) (34); and bipartite NLSs comprising two clusters of basic amino acids separated by a spacer of 10-12 amino acids (35). Both types of NLS are recognized by the conventional nuclear import receptor, the importin alpha /beta heterodimer (36-39), which mediates binding to the nuclear envelope, translocation through it, and release within the nucleus, in conjunction with other components of the nuclear import machinery such as the monomeric guanine nucleotide binding protein Ran. A number of proteins have been shown recently (40-43) to be able to be imported into the nucleus through an analogous pathway involving direct interaction with importin beta  independent of importin alpha .

A functional NLS within residues 369-405 of Dengue NS5, predicted to be an interdomain region of NS5 linking the S-adenosylmethionine transferase and polymerase domains (44), has been identified and demonstrated to be functional. This region contains three basic clusters resembling NLSs that are separated by spacer regions of 14 and 11 amino acid residues and is recognized by importin a/b (44). More recently we used the yeast two-hybrid (Y2H) system to show that the adjacent residues 320-368 interact with importin beta . Interestingly, we also showed that this same region also binds NS3 at either an identical or overlapping sequence (45).

In order to determine the functional significance of these sequences in the vicinity of the interdomain region of NS5, we set out to use site-directed mutagenesis and deletion analysis to define the essential elements of the importin a/b- and beta -binding sites in NS5 nuclear localization for the first time. We show that nuclear targeting conferred by NS5-(369-405) is predominantly through residues 369-389 (the "a/bNLS"), which is recognized by importin a/b, and that the bNLS (residues 320-368) is able to direct beta -gal to the nucleus of mammalian cells. Interestingly, the NS5-(369-405) region inhibits the ability of bNLS to transport beta -gal to the nucleus and also prevents the binding of importin beta  to the bNLS, whereas the bNLS inhibits the importin a/b-binding and nuclear targeting abilities of the a/bNLS. This suggests that there may be important functional significance for the physical proximity of the a/b- and bNLSs in regulating the nuclear entry of NS5 during the late stage of Dengue infection, with the homology of these sequences comparable to gene products from a range of flaviviruses, implying wider importance.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cell Culture-- Cells of the HTC rat hepatoma tissue culture line (a derivative of Morris hepatoma 7288C) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. For in vitro nuclear transport assays cells were grown on glass coverslips for 2 days and then washed in intracellular buffer (110 mM KCl, 5 mM NaHCO3, 5 mM MgCl2, 1 mM EGTA, 0.1 mM CaCl2, 20 mM Hepes, pH 7.4, 1 µM dithiothreitol, 10 ng/ml leupeptin) just prior to mechanical perforation (46-50).

Plasmid Construction and Mutagenesis-- Standard recombinant DNA techniques were used for plasmid construction and to introduce point mutations. Den2 NS5 NLS beta -gal fusion constructs shown in Fig. 1 were constructed from plasmid pPR2-NS5-NLS (referred to as pPR2Nco-NS5CcN in Ref. 44), either after complete or partial removal of the DNA encoding NS5-NLS (corresponding to NS5 residues 369-405) as required, and insertion of DNA encoding the relevant new region of NS5 (residues 320-368). Prior to making the constructs shown in Fig. 1, plasmid pPR2-NS5-NLS was first subjected to partial BamHI digestion followed by treatment with T4 DNA polymerase (Promega) in order to delete the BamHI site downstream of the lacZ gene. The new plasmid pPR2-1B-NS5-NLS facilitated the cloning of relevant NS5 fragments into the unique BamHI site at the 5' end of lacZ to make the various fusion protein-expressing plasmid constructs used in this study.

Gene fragments were generated by standard PCR procedures using Taq polymerase (Promega), appropriate primers, and template. The NLS mutants and the a/bNLS were obtained by PCR utilizing pPR2-1B-NS5-NLS as a template and the combinations of the desired mutagenic primers, general primers, or primer for NS5-(386-405) (see Table I), except for the mutant KN123 which used a previously created mutant template pPR2-1B-NS5-NLSKN2 and the two mutagenic primers to give the remaining mutations. Plasmid pMJNS5 (45) was used as the template for amplification of regions for the cloning of the bNLS fusion constructs. Amplified products were subsequently digested with the appropriate restriction enzymes and ligated into pPR2-1B-NS5-NLS similarly digested with the corresponding restriction enzymes.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Primers used to generate NS5 fusion protein expression constructs
Primer names indicate regions targeted, the orientation (in parentheses), and restriction sites used. Underlined nucleotides within primers indicate restriction sites, and nucleotides in bold denote introduced mutations. The general primers (d) have been described previously (44).

Plasmid pPR2-1B-NS5-a/bNLS (NS5 amino acids 369-391) was created by digestion of pPR2-1B-NS5-NLS with AvrII and BamHI followed by digestion with mung bean nuclease and ligation. All plasmid constructs were verified by DNA sequencing. T-ag amino acids 111-135 fused to beta -galactosidase (51) was used as a control.

Expression, Purification, and Fluorescent Labeling of beta -Galactosidase Fusion Proteins-- Escherichia coli strain MC1060 (52) bearing the plasmid encoding NS5-beta -gal fusion protein was grown in LB medium supplemented with 100 µg/ml ampicillin and induced with 400 µM isopropyl-1-thio-beta -D-galactopyranoside for 3 h at 37 °C. Purification of the fusion protein using an 4-aminophenyl-beta -D-thiogalactopyranoside (Roche Molecular Biochemicals) affinity column and subsequent labeling with the fluorescent dye 5-iodoacetamidofluorescein was carried out essentially as described (46, 51).

In Vitro Nuclear Import Assay-- In vitro nuclear import assays using mechanically perforated HTC cells in conjunction with confocal laser scanning microscopy (CLSM; Bio-Rad Radiance 2000) were performed as described previously (44, 46). Briefly, adherent HTC cells were grown on glass coverslips and mechanically perforated to generate intact nuclei that could be reconstituted to carry out nuclear import in the presence of exogenous cytoplasmic extract (untreated reticulocyte lysate; Promega), an ATP-regenerating system (0.125 mg/ml creatine kinase, 30 mM creatine phosphate, 2 mM ATP), and transport substrate (0.2 mg/ml of 5-(iodoacetamido)fluorescein-labeled fusion protein).

Image analysis for quantitation of fluorescence from CLSM was performed using NIH/Scion Image processing software as described previously (30, 48, 53). Curves were fitted for the function Fn/c(t) = Fn/cmax(1 - e-kt), where t is time in minutes; Fn/cmax is the maximal level of nuclear accumulation; and k is the first-order rate constant (46, 54-56).

Importin Binding Assay-- Mouse importin alpha - and importin beta -glutathione S-transferase (GST) fusion proteins were expressed in E. coli and purified as described previously (48). The GST was cleaved from GST-importin alpha  using thrombin, which was separated from the latter as described previously (57). Binding of importin subunits to beta -galactosidase fusion proteins was determined using an ELISA-based binding assay as described (48, 56). Briefly, fusion proteins (0.5 µg/well) were coated overnight at 4 °C in 96-well microtiter plates (Nunc). After blocking, appropriate dilutions of GST-importin alpha , GST-importin beta , or precomplexed GST-importin alpha /beta were then added to the wells and incubated for 16 h at 4 °C. Bound importin was detected using goat anti-GST and rabbit anti-goat IgG alkaline phosphatase-conjugated antibodies (Sigma) and the colorimetric substrate p-nitrophenyl phosphate. A405 was followed with time using a plate reader (Molecular Devices), with values corrected by subtracting both the absorbance at 0 min and that for wells incubated without importins. Correction was made for differences in coating efficiency as described previously (48, 56) using a parallel beta -galactosidase ELISA. Curves were fitted for the function B(x) = Bmax (1 - e-kx), where x is the concentration of importins, and k is the first-order rate constant (58).

GST Pull-down Assays of NS5 with GST-tagged Importin beta  or Its Complex with Importin alpha -- Histidine-tagged NS5 and NS3 were expressed in E. coli strain AD494(DE3)(RIL) and purified using nickel-chelating chromatography.2 157.5 pmol of GST-importin beta  (157.5 pmol) or importin alpha /GST-importin beta  was added to 40 µl of glutathione-Sepharose 4B resin (Amersham Biosciences AB) in pull-down buffer (20 mM Tris-HCl, pH 7.9, 140 mM NaCl, 20 mM MgCl2, and 0.1% Triton X-100) to a final volume of 100 µl and incubated at 4 °C with slow head-to-head mixing using a orbital rotor. The samples were centrifuged for 2 min at 7500 rpm at 4 °C, and the resin washed with 200 µl of pull-down buffer. The His-tagged NS5 (40.4 pmol) on its own or with equimolar His-tagged NS3 (44 pmol for 1 time and 440 pmol for 10 times) was added to the appropriate protein-bound resin in a final volume of 200 µl and incubated overnight (14-18 h) at 4 °C. The beads were washed 5 times with the pull-down buffer, and proteins were eluted with 50 mM Tris-HCl, pH 8.0, containing 60 mM reduced glutathione and 100 mM NaCl. The eluted fractions were separated on 10% SDS-PAGE, transferred to nitrocellulose membrane, detected with mouse polyclonal NS5 antibody (45), and visualized with ECL (Amersham Biosciences AB).

Homology Modeling-- The crystal structure of the complex of importin beta  with the importin beta  binding (IBB) region of importin alpha  (Protein Data Bank code 1QGK) was used to mutate the amino acid region 13-20 of importin alpha  to the corresponding amino acids 353-360 of Den2 NS5 (see Fig. 6), and the packing of all mutated residues was assessed using the crystallography software package O (59). The potential collision between the side-chains of F17E and importin beta  Trp-342 was manually adjusted, and the model was refined by molecular dynamic energy minimization using crystallography NMR software (60). The root mean square deviations Calpha atoms between the new model and the crystal structure is only 0.84 6Å, although the Calpha of residues 15-18 moved around 1.1 to 1.7 Å. A new hydrogen bond (3.1 Å) was formed between E17 OE1 and Val-350 N.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The N-terminal Charge Cluster in the 37-Residue Interdomain Region of NS5 Is Critical for Nuclear Localization-- We have previously localized a functional importin a/b-recognized NLS to the 37-amino acid interdomain region (residues 369-405) of Dengue 2 NS5 (44) and more recently shown that the N-terminally adjacent residues (320-368) interact with both importin beta  and the viral helicase NS3 (45). Residues 369-405 include three clusters of basic amino acid residues that resemble either three monopartite or two bipartite NLSs where the middle cluster of three positively charged lysine residues may be shared with either the N-terminal or C-terminal cluster. To test which of these residues are critical for NLS function, the lysine residues at positions 371 and 372 (KN1), 388 and 389 (KN2), and arginine at position 401 and lysine 402 (KN3) were altered by site-directed mutagenesis to asparagine separately or in combination (KN123, where all six positions were changed) as indicated (see Fig. 1). The encoded NS5-NLS-beta -gal fusion proteins were overexpressed, purified, and fluorescently labeled (see "Materials and Methods") and then added to mechanically perforated HTC cells together with an ATP-regenerating system and exogenous cytosol to assess nuclear import kinetics using CLSM. Fig. 2 shows that NS5 amino acids 369-405 targeted beta -gal to the nucleus maximally to levels about 2-fold those in the cytoplasm (Fn/cmax = 1.9) (44). beta -Gal itself was excluded from the nucleus (Fn/cmax of 0.5, see Table II). Examination of KN1, KN2, KN3, and KN123 (Fig. 2B, i) indicated that both the Fn/cmax and t1/2 (the time at which half-maximal nuclear accumulation is achieved) values were altered (Table II). The mutations in KN3 had the least effect compared with wild-type, whereas the nuclear import data for KN2 indicated an Fn/cmax of around 1.0. More drastic reductions in Fn/cmax were evident for KN1 and KN123, where the level of nuclear accumulation was not significantly above that of beta -gal alone (Table II). Taken together, this suggests that the charged clusters KN1 and KN2 represent critical elements of the NLS.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic representation of NS5 and the NS5beta -gal fusion proteins used in this study. The NS5 amino acid sequence from residue 320-405 is presented in the single letter amino acid code, with hatched boxes indicating the linker region of the plasmid vector pPR2-Nco and the shaded boxes indicating the NS5 sequences. The basic residues (K or R) in the a/bNLS region that have been mutated to asparagine (N) are indicated in bold at the analogous positions in the mutant constructs. Broken lines indicate regions not included in the various fusion constructs. The importin beta  binding region (residues 320-368) is referred to as the bNLS in the text, by way of contrast to the a/bNLS region, which is recognized by the importin alpha /beta heterodimer (see "Results").


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro nuclear import of various constructs of the NS5 interdomain region fused to beta -galactosidase. A, CLSM images of nuclear accumulation after 35-40 min within mechanically perforated HTC cells in the presence of exogenous cytosol and an ATP-regenerating system of beta -galactosidase fusion proteins containing NS5 residues (i) 369-405, (ii) 369-389 (also referred to as a/bNLS), (iii) 320-369 (also referred to as bNLS), (iv) NS5-(369-405)-KN1, (v) 386-405, and (vi) 320-405. B, quantitative data for nuclear import kinetics of NS5 interdomain beta -galactosidase fusion proteins in mechanically perforated HTC cells. Experiments were performed as described in A. Results are for (i) NS5 residues 369-405 and the same residues carrying mutations in the three basic clusters KN1, KN2, and KN3 (see Fig 1); (ii) the two NLS truncations a/bNLS and NS5-(368-405) compared with NS5-(368-405); and (iii) bNLS compared with NS5-(369-405), NS5-(320-405), and NS5-(341-405). Data points represent the average of 6-8 separate measurements for each nuclear (Fn), cytoplasmic (Fc), and background (autofluorescence) fluorescence. Curves were fitted for the function Fn/c(t) = Fn/cmax(1 - e-kt), where t is time in minutes; Fn/c is defined as the ratio of nuclear to cytoplasmic fluorescence; and k is the first-order rate constant (46, 56); regressions for the curve fits were not less than 0.92 and were in most cases >0.95. Results represent the average of three separate experiments with pooled data in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table II
In vitro nuclear import kinetics of NS5 peptide-beta -galactosidase fusion proteins
From experimental data such as that presented in Fig. 2B, curves were fitted for the function Fn/c(t) = Fn/cmax(1 - e-kt), where t is time in minutes; Fn/cmax is the maximal level of nuclear accumulation, and k is the first-order rate constant (46, 56). Results shown are for mean ± S.E., with n indicated. t1/2 is the time taken to achieve half-maximal level of nuclear accumulation.

To confirm this, plasmid constructs expressing beta -gal fusion proteins carrying either the N-terminal (amino acid residues 369-391) or C-terminal (amino acid residues 386-405) portion of the NS5 interdomain region were derived (see Fig. 1), and the proteins were expressed, labeled, and assayed for nuclear import. Fig. 2, A and B, ii, show that residues 369-389 confer nuclear accumulation to a level comparable with that conferred by residues 369-405 (Table II). In contrast, residues 386-405 conferred poor nuclear accumulation (Fn/cmax of around 1). The results with the truncated constructs indicated that residues 369-389 constitute the minimal NLS of the NS5 interdomain and were thus consistent with the results for site-directed mutagenesis where the mutations of residues 371 and 372 affected the greatest reduction in nuclear accumulation of beta -gal. We denote residues 369-389 the a/bNLS, recognized by importin alpha /beta (see below), to differentiate it from the bNLS (renders 320-368).

The NS5 Importin beta  Binding (bNLS) Region of NS5 Is a Functional Nuclear Localization Signal-- We next addressed the question of whether the importin beta  binding region (bNLS, residues 320-368) of NS5 (45), immediately N-terminal to the a/bNLS, is able to function as an NLS. Fusion protein NS5-bNLS-beta -gal (Fig. 1) was expressed, purified, fluorescently labeled, and examined in the in vitro transport assay using mechanically perforated HTC cells. Fig. 2B, iii, shows that although NS5-bNLS-beta -gal accumulated in the nucleus of the HTC cells marginally better than NS5-NLS-(369-405)-beta -gal, accumulation of the former was significantly (p < 0.006) slower, with the t1/2 of ~10 min over 3-fold higher than that of fusion proteins containing NS5-(369-405) or the a/bNLS (t1/2 of ~2-3 min) (Table II). Clearly, however, the bNLS is a functional NLS.

Mapping studies using the Y2H system and full-length and subdomain constructs of NS5 had indicated that the bNLS region (residues 320-368) is important for competitive binding of importin beta  and NS3. Surprisingly, constructs that contained both the bNLS and the 37-amino acid NLS region (residues 320-405) displayed only very weak interaction with importin beta  in the Y2H assay (45). To explore this phenomenon of inhibition of importin beta  binding by NS5 residues 369-405, a beta -gal fusion protein containing NS5 residues 320-405 was tested for its ability to accumulate in the nucleus of HTC cells. NS5-(320-405)-beta -gal construct showed markedly reduced accumulation compared with both the bNLS- or NS5-(369-405)-containing beta -gal fusion proteins (Fig. 2B, iii; Table II). Fusion protein NS5-(341-405)-beta -gal was also poorly transported to the nucleus (Fig. 2B, iii; Table II), indicating that residues 320-340 were not specifically responsible for this effect.

Importin beta  or alpha /beta Can Bind Directly to the NS5 bNLS/NLS Region-- Although the bNLS clearly represented a functional NLS additional to the previously characterized a/bNLS, the results from the in vitro nuclear transport assay did not enable us to exclude the possibility that the observed nuclear accumulation was due to the action of importin alpha /beta because both importin alpha  and beta  are present in the exogenous cytosol added. To clarify this, direct binding of importin alpha , importin beta , or the importin alpha /beta heterodimer to the various fusion proteins expressing the different NS5 regions were assessed using an ELISA-based assay (see "Materials and Methods").

Fig. 3B (see also Table III) clearly shows that only NS5-bNLS-beta -gal was recognized strongly by importin beta  with a Kd in the low nanomolar range. None of the other fusion proteins tested, including the construct that contained both the bNLS and NLS (i.e. residues 320-405), displayed any measurable recognition by importin beta  in the absence of importin alpha . Clearly, the bNLS region of NS5 is recognized by importin beta , but the additional presence of residues 369-405, including the a/bNLS, prevents importin beta  from binding to that site, implying a masking and/or conformational effect.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Measurement of the affinity of binding of importins to NS5-beta -galactosidase fusion proteins as determined using an ELISA-based binding assay. Measurements were performed as described under "Materials and Methods" (48, 56) and fitted to the function B(x) = Bmax·(1 - e-kt), where x is the importin concentration. The results are from a single typical experiment performed in triplicate, with pooled results in Table III.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Affinities of importin binding to NS5-beta -gal fusion proteins as determined using an ELISA-based binding assay

Binding studies with importin alpha  alone and the importin alpha /beta heterodimer confirmed the strong binding previously observed with NS5-NLS-beta -gal (44); as observed previously, binding affinity was much greater for the latter because of the fact that in the absence of importin beta  importin alpha  is autoinhibited (61, 62). The a/bNLS (residues 369-389) fusion protein construct was recognized by importin alpha /beta with affinity comparable with NS5-(369-405)-beta -gal, suggesting that residues 369-389 constitute the minimal importin alpha /beta heterodimer binding region, and correlating nicely with the nuclear transport results (above) indicating that these residues represent the minimal region with full nuclear targeting function. The poorest binding for the importin alpha /beta heterodimer was recorded for the bNLS construct fused to beta -gal, whereas the NS5-(386-405) and the NS5-(320-405) constructs displayed weak but measurable binding with Kd values around 100 nM (Fig. 3; Table III).

Intriguingly, as for the bNLS where the presence of the a/bNLS impaired importin beta  binding, the NS5-(320-405) construct was not recognized with high affinity by the importin alpha /beta heterodimer, indicating that the presence of the bNLS impinged on the recognition of the a/bNLS by importin alpha /beta . Again, this was consistent with masking and/or conformational effects modulating importin access to the two NLSs.

Thus, NS5-(369-389), the a/bNLS recognized by the importin alpha /beta heterodimer, and NS5-(320-369), the bNLS recognized by importin beta , represent functional NLSs, recognized with high affinity by their respective nuclear import receptors. That proteins containing both NLSs are not recognized with high affinity by importins implies that there may be complex regulation of the importin binding process; because NS3 also binds to the bNLS region (45), it seems probable that competition for binding to NS5 between importins and NS3 occurs, which is likely to be of physiological significance in the context of Dengue infection.

NS3 Binds the bNLS Site but Not the a/bNLS-- We had shown previously that GST-importin beta  can pull-down full-length His-tagged NS5, confirming the interaction between these two proteins originally observed using the Y2H system (45), whereas binding of the importin alpha /beta heterodimer to NS5-NLS-beta -gal has been shown previously as well as in the present study (44). In order to demonstrate that purified full-length NS5 can also interact with the importin alpha /beta heterodimer and to investigate the level to which the NS3-binding site overlaps with the bNLS and a/bNLS sites, pull-down assays were carried out as described under "Materials and Methods." The ability of either importin alpha /beta heterodimer or importin beta  to pull-down NS5 either in the absence (Fig. 4, lanes 2 and 5, respectively) or presence of equimolar (lanes 3 and 6) or 10-fold excess (lanes 1 and 3) of NS3 was analyzed by SDS-PAGE separation followed by Western blotting (Fig. 4). The result clearly shows for the first time that, through the a/bNLS, the importin alpha /beta heterodimer interacts with full-length NS5. Based on the amount of the NS5 pulled down (compare lanes 2 and 4), it is possible to conclude that the binding affinity of the importin alpha /beta heterodimer for NS5 may be lower than that of importin beta . This is despite the similar Kd value observed for the binding of the NS5 peptides fused with beta -gal in the ELISA-based binding assay (see Table III), but this is not entirely surprising because the peptide binding may not be subject to the same steric constraints as the full-length protein. As shown previously, an unrelated coral protein fused to GST (45) and GST importin alpha  did not pull-down NS5 (data not shown). Also, the amount of NS5 pulled down when importin alpha  was added at the same time as NS5 to GST-importin beta  was similar to that observed with the precomplexed importin heterodimer (data not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   NS5 pull-down assay with importins. Precomplexed importin alpha /GST-importin beta  (lanes 1-3) or GST-importin beta  (lanes 4-6) bound to Glutathione-Sepharose 4B resin were incubated with NS5 in the absence or presence of equimolar or excess (10 times) NS3 as indicated and subjected to a pull-down assay as described under "Materials and Methods." The pulled down fractions were separated by 10% SDS-PAGE and visualized by immunoblotting using a specific anti-NS5 polyclonal antibody.

Arguably the most interesting result from Fig. 4 is that NS3 competes for the bNLS site that is recognized by importin beta , as described previously (45), whereas binding of the importin heterodimer alpha /beta to the a/bNLS site is unaffected by even a 10-fold molar excess of NS3 as indicated by the similar amount of NS5 pulled down (Fig. 4, lanes 1-3). This implies that while NS3 can compete for the bNLS with importin beta , it is not able to compete for the a/bNLS with importin alpha /beta .

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We have shown previously (44, 45) that the interactions of NS5 with the virus-encoded NS3 protein and other cellular factors such as importin alpha  or importin alpha /beta heterodimers map to a small sequence region within NS5 spanning residues 320-405. Within this region, the 37-amino acid linker sequence (369X2KKX14KKKX11RKX3405) contains the signal that can target the carrier beta -gal (476 kDa) to the nucleus (44). In this study we pinpoint lysine residues at positions 371 and 372 of Den2 NS5 as critical components of the signal for nuclear targeting. By using site-directed mutagenesis we altered these two residues to asparagine (hydrophilic and neutral side-chain) in the NS5 linker fused to beta -gal, and we demonstrated that the ability of the mutant NS5 sequence to transport beta -gal to the nucleus was abolished, i.e. the mutant fusion protein NS5-KN1-beta -gal is excluded from the nucleus in comparable fashion to beta -gal itself (Fig. 2, iv). Similar analysis of the central and C-terminal clusters of basic residues (KN2 and KN3) within the linker region indicates that NS5 residues 369-389 contain the NLS. Two observations support this assignment as follows: the demonstration of a similar level of nuclear localization of beta -gal fused to either NS5 residues 369-389 (a/b NLS) or residues 369-405 in the in vitro nuclear transport assay, and the binding affinity of the importin alpha /beta heterodimer is comparable for both NS5-a/bNLS-beta -gal and NS5-(369-405)-beta -gal.

We also show for the first time that the importin beta -recognized NS5 region 320-368 (bNLS), which was identified using the Y2H system, is a functional NLS. Intriguingly beta -gal fusion proteins that contain both bNLS and a/bNLS do not accumulate in the nucleus, suggesting that these two NLSs are engaged in some inhibitory interaction that prevents either signal from facilitating nuclear transport. This counteraction by the two NLSs has been shown using three independent methods. First, the Y2H results indicate almost no interaction between NS5 residues 320-405 and importin beta  or NS3 (45) but strong interactions of both with NS5 residues 320-368. Second, the results from the ELISA-based binding assay shown here show that importin beta  binds to NS5-bNLS-beta -gal with nanomolar affinity but does not bind NS5-(320-405)-beta -gal; similarly, importin alpha  binds to residues 369-405 but not in the presence of residues 320-368 or 341-368. Finally, the nuclear transport of NS5-(320-405)-beta -gal is greatly reduced by comparison with NS5-(320-368)-beta -gal and NS5-(369-405)-beta -gal, indicating that either the a/bNLS or bNLS is poorly functional in the presence of the other NLS. The mechanism of this apparent inhibitory interaction is difficult to ascertain at present, but it is tempting to speculate that it may indeed be an example of an intrasteric autoinhibition regulatory mechanism (62) centered around what appears to be a "hotspot" for protein interaction in NS5 (see below).

Our approach to understanding the interaction between Dengue NS5 and NS3 proteins has focused on the interdomain region of Dengue 2 NS5 that contains the functional bNLS and a/bNLS. Significantly, NS3 competes with importin beta  for the bNLS site (45). The importance of the NS5 interdomain region (residues 320-405) is also supported by alanine mutagenesis of different charged residues in a full-length infectious clone of Dengue 4, which demonstrated that the NLS region is critical for virus viability (63). In particular, mutation of residues 356/357 (likely to be important for interaction with importin beta , see Figs. 5 and 6 below), 387/388 (the equivalent of our KN2 mutant), or 388/389 (within the a/bNLS) all impairs viral replication (63), consistent with their role in interacting with importins and of course NS3 being of physiological importance. However, the primary sequence alignment of the NS5-(320-405) region of Dengue subtypes and other members of the flavivirus genus reveal strong sequence conservation within residues 386-405 which indicates a functional role. The sequence alignment also reveals that the bipartite a/bNLS is not readily apparent in Dengue 1 NS5 but is noticeable in Dengue 2-4 by comparison with other bipartite NLSs (35). In Dengue 2 NS5, the KN1 charge cluster (Lys-371 and Lys-372) is critical for nuclear localization as shown here, and similar dibasic residues are also present at the homologous site in YFV NS5 that has been shown to localize in the nucleus (28). The absence of basic residues at positions 371/372 in Dengue 1 NS5 raises the question whether the Dengue serotypes that have not been experimentally demonstrated to localize in the nucleus will indeed do so, because the bipartite NLS appears to be absent. Interestingly a candidate T-ag-type monopartite NLS (363PKAKRG) (see Introduction) is present in Dengue 1 interdomain linker region which suggests that yet further nuclear localization mechanisms may operate.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Alignment of sequences in the NS5-(320-405) region of Dengue 2 virus with other Dengue subtypes and representative members of the flavivirus genus. The three basic clusters KN1, KN2, and KN3 are shaded in light gray. The highly conserved 20-amino acid region within the bNLS is highlighted by a black background. A dash is used to signify a gap to give optimal alignment. The virus sequences shown (and their GenBankTM accession numbers) are as follows: Den2 TSV01 (AY037116), Den2 NGC (AF038403), Den1 (U88535), Den3 (M93130), Den4 (AF32657), Yellow Fever (X15062), West Nile (M12294), Kunjin (D00246), Japanese encephalitis virus (M55506), tick-borne encephalitis virus (U27495), Murray Valley encephalitis virus (AF161266), Rio Bravo (AF144692), cell-fusing agent (M9167). The residues Arg-353 and Lys-358 that are significant for binding to importin alpha  (see Fig. 6) are indicated by the arrowheads. Shown below the alignment is the secondary structure prediction using the PHD program of Rost and Sander (66): H, helix; L, loop; E, strand; dot, not able to be predicted.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 6.   Molecular model of importin beta  interaction with the NS5 bNLS region. A, primary sequence comparison of the N-terminal portion of the importin a IBB domain (human-hSRP1a; Rch1) and NS5 bNLS residues 350-360. B, interactions of the N-terminal portion of the importin a IBB domain (green) with the C-terminal helix of importin beta  (yellow) (69). C, model of interaction of the bNLS region residues 350-360 with importin beta , generated as described under "Materials and Methods" using the GRASP and RIBBONS programs, based on the Protein Data Bank coordinates for the importin alpha  peptide from Cingolani et al. (69) (see also "Discussion").

The most important result in the sequence alignment (Fig. 5) is the almost complete conservation of a 20-amino acid sequence (342AMTDTTPFGQQRVFKEKVDT) within the bNLS. The cell fusing agent virus that is tentatively classified as a member of the flavivirus genus (64) showed the greatest deviation from this conserved sequence motif. The significance of this region was demonstrated in a previous study by Khromykh and colleagues (65) using trans-complementation studies with a helper system that stably expressed the non-structural proteins of Kunjin virus. They showed that the deletion of the RNA encoding the entire polymerase domain of NS5 could be complemented, but the additional removal of the RNA encoding the 20-amino acid sequence within bNLS severely reduced rescue of the defective virus. The conserved 20-amino acid region has been referred to as "motif c" of the N-terminal region of NS5 and was speculated to bind NS3 and other non-structural proteins such as NS2A (65). Our previous demonstration that the helicase domain of Den2 NS3 binds to this conserved region of NS5 by Y2H assay and also biochemically in a pull-down assay (45) confirmed the speculation.

Secondary structure prediction of the conserved 20-amino acid sequence suggests that it most probably forms a loop region (66). Consistent with this is the idea that loops in protein ligands are the preferred motifs for promiscuous binding to different protein targets as is the case with signal transduction proteins that interact with multiple targets (67, 68). Structural studies have shown that part of the molecular recognition between importin beta  and importin alpha  occurs when the N-terminal part of the IBB (importin beta  binding) domain of the latter uses its two invariant residues, alpha Arg-13 and alpha Lys-18 (conserved in all importin alpha s), to snuggle into a spatially conserved arrangement of acidic and hydrophobic residues in importin beta  (Fig. 6) (69). Intriguingly, within the conserved 20-amino acid region of NS5 there are two invariable residues Arg-353 and Lys-358 that are identical and similarly spaced to the conserved residues in importin alpha  IBB. It is also very interesting that the alpha 17 position of the IBB which is either Phe or Tyr (in all importin alpha s) may be replaced by Glu (present at the analogous site of NS5) because its carboxylate group is within H-bonding distance from beta Lys-346, but homology modeling suggests that H-bonding of the Glu-17 OE1 occurs with the main chain amide nitrogen of beta Val-350 (Fig. 6). Furthermore, the predicted beta  strand within "motif c" (residues 354-356) forms a 310-helix similar to the importin alpha  IBB sequence and consequently the bulky aromatic side chain of NS5 Phe-356 points away from the binding pockets for Arg-353 and Lys-358. Our homology model of the NS5 motif c region is in agreement with the demonstration here that importin beta  binds strongly to the bNLS region.

Whether the importin beta  binding that has been mapped to this conserved region and shown here to be functional in nuclear transport assays is relevant for virus morphogenesis and/or pathogenesis is not yet clear, but based on all the available evidence this region of NS5 certainly warrants detailed study. We have already drawn attention to the fact that NS5A from hepatitis C virus, a member of the Flaviviridae family, interacts with an importin beta  homologue known as karyopherin-beta 3 (45). In that case, a putative hijacking role was ascribed for hepatitis C virus NS5A which suggested that the viral protein may sequester nuclear transport receptors and interfere with transport of cellular proteins to the nucleus (70). Consistent with the significantly slower rate of bNLS-mediated nuclear transport, relative to that mediated by the a/bNLS (see Table II), an interesting possibility in this context is that the bNLS may act through importin beta  as some sort of cytoplasmic retention signal for NS5, sequestering importin beta  at the same time, and preventing it from fulfilling its normal transport role.

Based on our results here and previously (45) with respect to the protein interactions we have identified using Y2H and in vitro techniques, we propose that a concerted series of events are likely to occur in a Dengue virus-infected mammalian cell. First, after synthesis the NS5-(320-405) region is most likely masked because of its interaction with NS3 (45, 65). Subsequent autoproteolysis of NS3 (71, 72) may expose the NS5-(320-368) region and allow importin beta  to bind the NS5 bNLS (the binding affinity of this interaction is comparable with that of importin beta  for importin alpha ). Importin alpha  is then recruited to this site and as a result of a conformational change the importin alpha /beta heterodimer then binds to the a/bNLS region and subsequently transports NS5 to the nucleus with reasonably high efficiency to impact on host cell nuclear functions. Lower efficiency importin beta -mediated nuclear transport may account for the cytoplasmic retention phenomenon that we have observed previously (44), but where phosphorylation may play a role in all of this is unclear. Of course, hard experimental evidence is needed to address the details of the various protein-protein interactions within the NS5-(320-405) region using full-length viral and host proteins. Based on our analysis, carefully selected mutations in this region may well assist in the development of an effective and rationally designed live attenuated virus, making a Dengue vaccine a step closer to being a realistic possibility. Finally, the high level of conservation of the bNLS region (Fig. 5) makes it an attractive potential target for a broad-acting bifunctional antiviral agent against flaviviruses that utilize the same replicative mechanism as Dengue.

    ACKNOWLEDGEMENTS

We thank Nadya Shale for technical assistance and Jade Forwood for the gift of importin beta .

    FOOTNOTES

* This work was supported by a grant from the National Health and Medical Research Council of Australia.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, James Cook University, Townsville, Queensland 4811, Australia. Tel.: 61-7-47814233; Fax: 61-7-47816078; E-mail: Subhash.Vasudevan@jcu.edu.au.

Published, JBC Papers in Press, June 24, 2002, DOI 10.1074/jbc.M204977200

2 M. Johansson, A. J. Brooks, and S. G. Vasudevan, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: YFV, yellow fever virus; NLS, nuclear localization signal; beta -gal, beta -galactosidase; T-ag, T-antigen; GST, glutathione S-transferase; ELISA, enzyme-linked immunosorbent assay; CLSM, confocal laser scanning microscopy; Y2H, yeast two-hybrid; IBB, importin beta  binding.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Halstead, S. B. (1988) Science 239, 476-481[Abstract/Free Full Text]
2. Henchal, E. A., and Putnak, J. R. (1990) Clin. Microbiol. Rev. 3, 376-396[Abstract/Free Full Text]
3. Huang, K. J., Li, S. Y., Chen, S. C., Liu, H. S., Lin, Y. S., Yeh, T. M., Liu, C. C., and Lei, H. Y. (2000) J. Gen. Virol. 81, 2177-2182[Abstract/Free Full Text]
4. Monath, T. P. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2395-2400[Abstract/Free Full Text]
5. Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., and Strauss, J. H. (1985) Science 229, 726-733[Abstract/Free Full Text]
6. Zhao, B., Mackow, E., Buckler-White, A., Markoff, L., Chanock, R. M., Lai, C. J., and Makino, Y. (1986) Virology 155, 77-88[CrossRef][Medline] [Order article via Infotrieve]
7. Kapoor, M., Zhang, L., Ramachandra, M., Kusukawa, J., Ebner, K. E., and Padmanabhan, R. (1995) J. Biol. Chem. 270, 19100-19106[Abstract/Free Full Text]
8. Edward, Z., and Takegami, T. (1993) Microbiol. Immunol. 37, 239-243[Medline] [Order article via Infotrieve]
9. Westaway, E. G., Mackenzie, J. M., Kenney, M. T., Jones, M. K., and Khromykh, A. A. (1997) J. Virol. 71, 6650-6661[Abstract]
10. Mackenzie, J. M., Jones, M. K., and Young, P. R. (1996) Virology 220, 232-240[CrossRef][Medline] [Order article via Infotrieve]
11. Mackenzie, J. M., Jones, M. K., and Westaway, E. G. (1999) J. Virol. 73, 9555-9567[Abstract/Free Full Text]
12. Grun, J. B., and Brinton, M. A. (1988) J. Gen. Virol. 69, 3121-3127[Abstract/Free Full Text]
13. Shi, P. Y., Li, W., and Brinton, M. A. (1996) J. Virol. 70, 6278-6287[Abstract]
14. Ta, M., and Vrati, S. (2000) J. Virol. 74, 5108-5115[Abstract/Free Full Text]
15. Blackwell, J. L., and Brinton, M. A. (1997) J. Virol. 71, 6433-6444[Abstract]
16. Li, H., Clum, S., You, S., Ebner, K. E., and Padmanabhan, R. (1999) J. Virol. 73, 3108-3116[Abstract/Free Full Text]
17. Krishna Murthy, H. M., Judge, K., DeLucas, L., and Padmanabhan, R. (2000) J. Mol. Biol. 301, 759-767[CrossRef][Medline] [Order article via Infotrieve]
18. Cui, T., Sugrue, R. J., Xu, Q., Lee, A. K., Chan, Y. C., and Fu, J. (1998) Virology 246, 409-417[CrossRef][Medline] [Order article via Infotrieve]
19. Wengler, G. (1993) Virology 197, 265-273[CrossRef][Medline] [Order article via Infotrieve]
20. Tan, B. H., Fu, J., Sugrue, R. J., Yap, E. H., Chan, Y. C., and Tan, Y. H. (1996) Virology 216, 317-325[CrossRef][Medline] [Order article via Infotrieve]
21. Steffens, S., Thiel, H. J., and Behrens, S. E. (1999) J. Gen. Virol. 80, 2583-2590[Abstract/Free Full Text]
22. Ackermann, M., and Padmanabhan, R. (2001) J. Biol. Chem. 276, 39926-39937[Abstract/Free Full Text]
23. Khromykh, A. A., Kenney, M. T., and Westaway, E. G. (1998) J. Virol. 72, 7270-7279[Abstract/Free Full Text]
24. Guyatt, K. J., Westaway, E. G., and Khromykh, A. A. (2001) J. Virol. Methods 92, 37-44[CrossRef][Medline] [Order article via Infotrieve]
25. Koonin, E. V. (1993) J. Gen. Virol. 74, 733-740[Abstract/Free Full Text]
26. Reed, K. E., Gorbalenya, A. E., and Rice, C. M. (1998) J. Virol. 72, 6199-6206[Abstract/Free Full Text]
27. Morozova, O. V., Tsekhanovskaya, N. A., Maksimova, T. G., Bachvalova, V. N., Matveeva, V. A., and Kit, Y. (1997) Virus Res. 49, 9-15[CrossRef][Medline] [Order article via Infotrieve]
28. Buckley, A., Gaidamovich, S., Turchinskaya, A., and Gould, E. A. (1992) J. Gen. Virol. 73, 1125-1130[Abstract/Free Full Text]
29. Westaway, E. G., Khromykh, A. A., Kenney, M. T., Mackenzie, J. M., and Jones, M. K. (1997) Virology 234, 31-41[CrossRef][Medline] [Order article via Infotrieve]
30. Jans, D. A. (1995) Biochem. J. 311, 705-716[Medline] [Order article via Infotrieve]
31. Jans, D. A., and Hubner, S. (1996) Physiol. Rev. 76, 651-685[Abstract/Free Full Text]
32. Gorlich, D. (1998) EMBO J. 17, 2721-2727[CrossRef][Medline] [Order article via Infotrieve]
33. Akey, C. W., and Goldfarb, D. S. (1989) J. Cell Biol. 109, 971-982[Abstract/Free Full Text]
34. Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. E. (1984) Nature 311, 33-38[CrossRef][Medline] [Order article via Infotrieve]
35. Jans, D. A., Chan, C. K., and Huebner, S. (1998) Med. Res. Rev. 18, 189-223[CrossRef][Medline] [Order article via Infotrieve]
36. Imamoto, N., Shimamoto, T., Kose, S., Takao, T., Tachibana, T., Matsubae, M., Sekimoto, T., Shimonishi, Y., and Yoneda, Y. (1995) FEBS Lett. 368, 415-419[CrossRef][Medline] [Order article via Infotrieve]
37. Moroianu, J., Blobel, G., and Radu, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2008-2011[Abstract/Free Full Text]
38. Adam, E. J., and Adam, S. A. (1994) J. Cell Biol. 125, 547-555[Abstract/Free Full Text]
39. Gorlich, D., Kostka, S., Kraft, R., Dingwall, C., Laskey, R. A., Hartmann, E., and Prehn, S. (1995) Curr. Biol. 5, 383-392[CrossRef][Medline] [Order article via Infotrieve]
40. Truant, R., and Cullen, B. R. (1999) Mol. Cell. Biol. 19, 1210-1217[Abstract/Free Full Text]
41. Xiao, Z., Liu, X., and Lodish, H. F. (2000) J. Biol. Chem. 275, 23425-23428[Abstract/Free Full Text]
42. Takizawa, C. G., Weis, K., and Morgan, D. O. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 7938-7943[Abstract/Free Full Text]
43. Lam, M. H., Hu, W., Xiao, C. Y., Gillespie, M. T., and Jans, D. A. (2001) Biochem. Biophys. Res. Commun. 282, 629-634[CrossRef][Medline] [Order article via Infotrieve]
44. Forwood, J. K., Brooks, A., Briggs, L. J., Xiao, C. Y., Jans, D. A., and Vasudevan, S. G. (1999) Biochem. Biophys. Res. Commun. 257, 731-737[CrossRef][Medline] [Order article via Infotrieve]
45. Johansson, M., Brooks, A. J., Jans, D. A., and Vasudevan, S. G. (2001) J. Gen. Virol. 82, 735-745[Abstract/Free Full Text]
46. Jans, D. A., Ackermann, M. J., Bischoff, J. R., Beach, D. H., and Peters, R. (1991) J. Cell Biol. 115, 1203-1212[Abstract/Free Full Text]
47. Jans, D. A., and Jans, P. (1994) Oncogene 9, 2961-2968[Medline] [Order article via Infotrieve]
48. Hubner, S., Xiao, C.-Y., and Jans, D. A. (1997) J. Biol. Chem. 272, 17191-17195[Abstract/Free Full Text]
49. Jans, D. A., Moll, T., Nasmyth, K., and Jans, P. (1995) J. Biol. Chem. 270, 17064-17067[Abstract/Free Full Text]
50. Lang, I., Scholz, M., and Peters, R. (1986) J. Cell Biol. 102, 1183-1190[Abstract/Free Full Text]
51. Rihs, H. P., and Peters, R. (1989) EMBO J. 8, 1479-1484[Medline] [Order article via Infotrieve]
52. Shapira, S. K., Chou, J., Richaud, F. V., and Casadaban, M. J. (1983) Gene (Amst.) 25, 71-82[CrossRef][Medline] [Order article via Infotrieve]
53. Xiao, C. Y., Hubner, S., Elliot, R. M., Caon, A., and Jans, D. A. (1996) J. Biol. Chem. 271, 6451-6457[Abstract/Free Full Text]
54. Jans, D. A., Briggs, L. J., Gustin, S. E., Jans, P., Ford, S., and Young, I. G. (1997) FEBS Lett. 406, 315-320[CrossRef][Medline] [Order article via Infotrieve]
55. Efthymiadis, A., Briggs, L. J., and Jans, D. A. (1998) J. Biol. Chem. 273, 1623-1628[Abstract/Free Full Text]
56. Efthymiadis, A., Shao, H., Hubner, S., and Jans, D. A. (1997) J. Biol. Chem. 272, 22134-22139[Abstract/Free Full Text]
57. Forwood, J. K., Harley, V., and Jans, D. A. (2001) J. Biol. Chem. 276, 46575-46582[Abstract/Free Full Text]
58. Briggs, L. J., Stein, D., Goltz, J., Corrigan, V. C., Efthymiadis, A., Hubner, S., and Jans, D. A. (1998) J. Biol. Chem. 273, 22745-22752[Abstract/Free Full Text]
59. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard. (1991) Acta Crystallogr Sect. A 47, 110-119[CrossRef]
60. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr Sect. D Biol. Crystallogr. 54, 905-921[CrossRef][Medline] [Order article via Infotrieve]
61. Kobe, B. (1999) Nat. Struct. Biol. 6, 388-397[CrossRef][Medline] [Order article via Infotrieve]
62. Catimel, B., Teh, T., Fontes, M. R., Jennings, I. G., Jans, D. A., Howlett, G. J., Nice, E. C., and Kobe, B. (2001) J. Biol. Chem. 276, 34189-34198[Abstract/Free Full Text]
63. Hanley, K. A., Lee, J. J., Blaney, J. E., Jr., Murphy, B. R., and Whitehead, S. S. (2002) J. Virol. 76, 525-531[Abstract/Free Full Text]
64. Cammisa-Parks, H., Cisar, L. A., Kane, A., and Stollar, V. (1992) Virology 189, 511-524[CrossRef][Medline] [Order article via Infotrieve]
65. Khromykh, A. A., Sedlak, P. L., and Westaway, E. G. (1999) J. Virol. 73, 9247-9255[Abstract/Free Full Text]
66. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232, 584-599[CrossRef][Medline] [Order article via Infotrieve]
67. Walter, M. R., Windsor, W. T., Nagabhushan, T. L., Lundell, D. J., Lunn, C. A., Zauodny, P. J., and Narula, S. K. (1995) Nature 376, 230-235[CrossRef][Medline] [Order article via Infotrieve]
68. Xu, Y., Cheah, E., Carr, P. D., van Heeswijk, W. C., Westerhoff, H. V., Vasudevan, S. G., and Ollis, D. L. (1998) J. Mol. Biol. 282, 149-165[CrossRef][Medline] [Order article via Infotrieve]
69. Cingolani, G., Petosa, C., Weis, K., and Muller, C. W. (1999) Nature 399, 221-229[CrossRef][Medline] [Order article via Infotrieve]
70. Chung, K. M., Lee, J., Kim, J. E., Song, O. K., Cho, S., Lim, J., Seedorf, M., Hahm, B., and Jang, S. K. (2000) J. Virol. 74, 5233-5241[Abstract/Free Full Text]
71. Arias, C. F., Preugschat, F., and Strauss, J. H. (1993) Virology 193, 888-899[CrossRef][Medline] [Order article via Infotrieve]
72. Teo, K. F., and Wright, P. J. (1997) J. Gen. Virol. 78, 337-341[Abstract]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Rawlinson, M. J. Pryor, P. J. Wright, and D. A. Jans
CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus Production
J. Biol. Chem., June 5, 2009; 284(23): 15589 - 15597.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Chernov, S. A. Shiryaev, A. E. Aleshin, B. I. Ratnikov, J. W. Smith, R. C. Liddington, and A. Y. Strongin
The Two-component NS2B-NS3 Proteinase Represses DNA Unwinding Activity of the West Nile Virus NS3 Helicase
J. Biol. Chem., June 20, 2008; 283(25): 17270 - 17278.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Sangiambut, P. Keelapang, J. Aaskov, C. Puttikhunt, W. Kasinrerk, P. Malasit, and N. Sittisombut
Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection
J. Gen. Virol., May 1, 2008; 89(5): 1254 - 1264.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. L. Yap, T. Xu, Y.-L. Chen, H. Malet, M.-P. Egloff, B. Canard, S. G. Vasudevan, and J. Lescar
Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution
J. Virol., May 1, 2007; 81(9): 4753 - 4765.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Malet, M.-P. Egloff, B. Selisko, R. E. Butcher, P. J. Wright, M. Roberts, A. Gruez, G. Sulzenbacher, C. Vonrhein, G. Bricogne, et al.
Crystal Structure of the RNA Polymerase Domain of the West Nile Virus Non-structural Protein 5
J. Biol. Chem., April 6, 2007; 282(14): 10678 - 10689.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J. M. Mackenzie, M. T. Kenney, and E. G. Westaway
West Nile virus strain Kunjin NS5 polymerase is a phosphoprotein localized at the cytoplasmic site of viral RNA synthesis
J. Gen. Virol., April 1, 2007; 88(4): 1163 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
I. Umareddy, A. Chao, A. Sampath, F. Gu, and S. G. Vasudevan
Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA
J. Gen. Virol., September 1, 2006; 87(9): 2605 - 2614.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. D. Uchil, A. V. A. Kumar, and V. Satchidanandam
Nuclear localization of flavivirus RNA synthesis in infected cells.
J. Virol., June 1, 2006; 80(11): 5451 - 5464.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Xu, A. Sampath, A. Chao, D. Wen, M. Nanao, P. Chene, S. G. Vasudevan, and J. Lescar
Structure of the Dengue Virus Helicase/Nucleoside Triphosphatase Catalytic Domain at a Resolution of 2.4 A
J. Virol., August 15, 2005; 79(16): 10278 - 10288.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/39/36399    most recent
M204977200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brooks, A. J.
Right arrow Articles by Vasudevan, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brooks, A. J.
Right arrow Articles by Vasudevan, S. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement